Mangafodipir

In the US, Mangafodipir (mangafodipir systemic) is a member of the drug class magnetic resonance imaging contrast media.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA05

CAS registry number (Chemical Abstracts Service)

0155319-91-8

Chemical Formula

C22-H30-Mn-N4-O14-P2

Molecular Weight

691

Therapeutic Category

Paramagnetic contrast media

Chemical Name

Hexahydrogen (OC-6-13)-[[N,N'-ethylenebis[N-[[3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl]methyl]glycine] 5,5'-bis-(phosphato)](8-)]manganate(6-) (WHO)

Foreign Names

  • Mangafodipirum (Latin)
  • Mangafodipir (German)
  • Mangafodipir (French)
  • Mangafodipir (Spanish)

Generic Names

  • Mangafodipir (OS: BAN)
  • MnDPDP (IS)
  • S 095 (IS)
  • Mangafodipir Trisodium (OS: BANM, USAN)
  • Win 59010-2 (IS)
  • Mangafodipir trisodium (PH: USP 34)

Brand Names

  • Teslascan
    Amersham, Greece; Amersham, Hungary; Amersham Health, Spain; GE Healthcare, Czech Republic; GE Healthcare, Germany; GE Healthcare, Lithuania; GE Healthcare, Luxembourg; GE Healthcare, Latvia; Nycomed, Slovenia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)